Latent Labs has raised $50 million of new funding as it commercialises its GenAI technology for designing new proteins for ...
A new startup from one of the key scientists at Google DeepMind exits stealth today with $50 million in funding.
Latent Labs hopes to take computational biology one step further. The company is developing foundation AI models that don’t ...
Isomorphic Labs, a spin-off from DeepMind, is applying AI-first principles to drug discovery rather than just protein ...
As part of the funding, Latent Labs aims to leverage generative artificial intelligence to computationally create novel ...
Hosted on MSN1d
Startups Defy Economic Headwinds with Breakthrough FundingLatent Labs, an AI biotech startup, has emerged from stealth mode with a remarkable $50 million funding boost. Founded by a ...
The company is developing generative AI methods to design proteins from scratch, with applications in drug discovery and ...
Backed by influencial names in the life sciences industry, Latent Labs offers an AI platform to accelerate and improve drug ...
You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life ...
Former DeepMind employees raise $40 million to launch London-based startup 'laser-focused' on AI protein design.
The frontier AI lab enables biotech and pharmaceutical companies to generate and optimize proteins. Latent Labs, the company building AI foundation models to make biology programmable, today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback